PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.43%
Revenue growth of 1.43% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
-0.51%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
51.44%
EBIT growth of 51.44% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
1.06%
Operating income growth of 1.06% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
52.44%
Net income growth of 52.44% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
52.44%
EPS growth exceeding 1.5x Healthcare median of 3.45%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
52.44%
Diluted EPS growth exceeding 1.5x Healthcare median of 3.69%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
0.00%
Share reduction exceeding 1.5x Healthcare median of 0.27%. Joel Greenblatt would applaud significant buybacks if they are value-accretive.
0.00%
Diluted share reduction exceeding 1.5x Healthcare median of 0.26%. Joel Greenblatt would see a meaningful advantage if shares are undervalued.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.55%
10Y CAGR of 52.55% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
59.61%
5Y CAGR of 59.61% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
26.86%
3Y CAGR of 26.86% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
100.00%
OCF/share CAGR of 100.00% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
222.32%
Net income/share CAGR of 222.32% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
177.62%
Net income/share CAGR of 177.62% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
107.89%
3Y net income/share CAGR of 107.89% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
194.93%
Equity/share CAGR of 194.93% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
125.91%
5Y equity/share CAGR of 125.91% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
59.94%
3Y equity/share CAGR of 59.94% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reductions while Healthcare median grows. Seth Klarman sees a near-term disadvantage if peers maintain or raise payouts.
10.26%
AR growth of 10.26% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
-1.27%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
1.24%
Asset growth of 1.24% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
4.71%
BV/share growth of 4.71% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-5.89%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-0.94%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.